#India #Mumbai #Sustainability Report #Piramal Pharma #FDA Observations

Piramal Pharma's Groundbreaking Sustainability Efforts

In an impressive display of commitment to environmental sustainability, Piramal Pharma Limited has announced significant achievements in its latest Sustainability Report for 2025-2026. The report showcases the company's proactive steps towards reducing its ecological footprint and ensuring a sustainable future for its operations. With a focus on innovation and responsibility, Piramal Pharma has outlined critical reductions in greenhouse gas emissions and has made considerable investments towards renewable energy resources.

Key Highlights from the Report

Piramal Pharma has successfully recorded a 22.6% reduction in Scope 1 and Scope 2 greenhouse gas emissions compared to the 2022 baseline. This achievement is pivotal as it reflects the organization's ongoing commitment to meeting its Science-Based Targets initiative (SBTi) approved decarbonization roadmap. In addition, renewable energy consumption across all operations has surged to 41% of the total energy usage. These numbers are not just figures; they stand as testament to Piramal's dedication to environmental stewardship.

The reduction in emissions and transition to cleaner energy sources is paired with impressive waste management strategies. The company has reported the recycling and reuse of 2.63 kiloliters of fresh water, accompanied by a diversion of 65% of total waste from landfills, further demonstrating its commitment to resource efficiency.

Quality and Operational Excellence

Beyond environmental achievements, the report proudly outlines Piramal Pharma's operational integrity. During the reported period, the company successfully completed 38 regulatory inspections, including three by the U.S. FDA, with absolutely zero official action inspections (OAI) noted. This reinforces the company’s high standards in quality and compliance, supporting its global manufacturing network’s reliability.

Moreover, Piramal's proactive approach towards digital transformation has further strengthened its operations. The integration of advanced systems like Catalyst NxGen and SAP S/4HANA into its quality management processes ensures a future-ready framework capable of maintaining industry standards.

Community Engagement and Governance

Piramal's commitment spans beyond emissions and operational standards. The company has made considerable contributions towards community development, investing approximately 8.98 crores in CSR initiatives impacting nearly 1.8 million people across 112 districts. Their focus remains on healthcare and educational programs, thereby strengthening community engagement and stakeholder trust.

Additionally, the governance structure reflects diversity, with women representing 30% of the board and 20.1% of the overall workforce. Such inclusivity highlights their ongoing efforts towards creating a balanced workplace.

A Vision for the Future

Nandini Piramal, the Chairperson of Piramal Pharma, emphasizes that sustainability is not merely an obligation but a driver for innovation and long-term resilience. The company views its sustainability initiatives as avenues for growth and better health outcomes, establishing a vital link between social responsibility and business success. As they forge ahead, the goal remains clear: to create a future-ready organization that prioritizes health outcomes, builds robust communities, and delivers sustainable value to all stakeholders.

The detailed sustainability framework encompasses four strategic pillars: business resilience, quality excellence, responsible operations, and stakeholder orientation, backed by over 50 sustainability-related goals. This ambitious framework reaffirms Piramal Pharma's commitment to sustainable business practices, aligning with the Global Reporting Initiative (GRI) standards and maintaining adherence to the Sustainability Accounting Standards Board (SASB) and United Nations Global Compact (UNGC) guidelines.

For a comprehensive view of their achievements and strategies, Piramal Pharma's full sustainability report is available online, reflecting a resilient organization poised for future challenges while remaining dedicated to environmental and social governance.

In a world increasingly focused on sustainability, Piramal Pharma stands as a role model in the pharmaceutical industry, demonstrating that responsible practices can go hand in hand with business success.